Vimarsana
Biggest News Aggregation in the World

Page 37 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Sciences Today - Breaking & Trending Today

BIO-TECHNE LAUNCHES NEW TURBO CE-SDS™ CARTRIDGE, ACCELERATING PROTEIN PURITY ANALYSIS THROUGHPUT BY 400% - Vimarsana News

BIO-TECHNE LAUNCHES NEW TURBO CE-SDS™ CARTRIDGE, ACCELERATING PROTEIN PURITY ANALYSIS THROUGHPUT BY 400%

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, has launched the innovative Maurice™ Turbo CE-SDS...

Affiance Financial LLC Decreases Stake in Bio-Techne Co. (NASDAQ:TECH) - Vimarsana News

Affiance Financial LLC Decreases Stake in Bio-Techne Co. (NASDAQ:TECH)

Affiance Financial LLC lowered its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 7.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,258 shares of the biotechnology company’s stock after selling 473 shares during the quarter. Bio-Techne accounts for about […]

New Mexico Educational Retirement Board Sells 100 Shares of Bio-Techne Co. (NASDAQ:TECH) - Vimarsana News

New Mexico Educational Retirement Board Sells 100 Shares of Bio-Techne Co. (NASDAQ:TECH)

New Mexico Educational Retirement Board trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 4.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,300 shares of the biotechnology company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings […]

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at Zacks Investment Research - Vimarsana News

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at Zacks Investment Research

Bio-Techne (NASDAQ:TECH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm currently has a $408.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.79% from […]

Charles R. Kummeth Sells 5,104 Shares of Bio-Techne Co. (NASDAQ:TECH) Stock - Vimarsana News

Charles R. Kummeth Sells 5,104 Shares of Bio-Techne Co. (NASDAQ:TECH) Stock

Bio-Techne Co. (NASDAQ:TECH – Get Rating) CEO Charles R. Kummeth sold 5,104 shares of the company’s stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $365.00, for a total transaction of $1,862,960.00. Following the transaction, the chief executive officer now directly owns 198,338 shares in the company, […]